Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana
Richard O. Phillips
, Michael Frimpong, Fred S. Sarfo, Birte Kretschmer, Marcus Beissner, Alexander Debrah, Yaw Ampem-Amoako, Kabiru M. Abass, William Thompson, Mabel Sarpong Duah, Justice Abotsi, Ohene Adjei, Bernhard Fleischer, Gisela Bretzel, Mark Wansbrough-Jones, and Marc Jacobsen
Author affiliations: Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (R.O. Phillips, A. Debrah); Komfo Anokye Teaching Hospital, Kumasi (R.O. Phillips, F.S. Sarfo, Y. Ampem-Amoako, O. Adjei); Kumasi Collaborative Centre for Research, Kumasi (M. Frimpong, M. Sarpong Duah); Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany (B. Kretschmer, B. Fleischer); University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany (M. Beissner, G. Bretzel); Agogo Presbyterian Hospital, Agogo, Ghana (K.M. Abass, W. Thompson, J. Abotsi); St. George’s University of London, London, UK (M. Wansbrough-Jones); University Children’s Hospital, Dusseldorf, Germany (M. Jacobsen)
Figure 2. Survival analysis curve of cumulative healing for patients with Mycobacterium ulcerans infection who were co-infected with Mansonella perstans nematodes compared with those who had Mulcerans monoinfection, Ghana, August 2010–December 2012No difference in cumulative healing was found between the 2 groups (p = 0.93 by log-rank test).
Page created: May 16, 2014
Page updated: May 16, 2014
Page reviewed: May 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.